Matrix search results

Effectiveness bank home page. Opens new window Matrix search results

You have found 212 entries after clicking on a search link (usually the MORE information link) in a matrix cell. Starting with analyses of the most recently published documents, the list shows in orange the type of entry, year the original document was published (or if one of our own documents, the year last updated), and the type of file you will download when you click on the title. In blue is the document’s title followed by a brief description.

Click blue titles to view full text in a new window
Use the selectors at the bottom to turn to the next page in the list of documents
Re-order the list by the most recently added or updated entries or by the main topic addressed


If you have not found what you want you could:
Select from the full range of topics and search options available on our topic search page.
Instead try a free text search for documents which contain the words you specify.
Or try browsing back issues of the magazine or recent bulletins.
Documents are regularly added. Use the e-mail update service to monitor additions.
Try the information services provided by partner agencies.
Tried everything? E-mail the Findings editor for help by clicking on this logo Drug and Alcohol Findings logo



STUDY 2005 PDF file 154Kb
Hepatitis C therapy cost-effective for injectors

Two new analyses agree that despite relapse to drug use and imperfect adherence to a demanding medical regime, anti-viral therapy for hepatitis C infection in drug injectors cost-effectively prolongs and improves life.

STUDY 2005 PDF file 180Kb
Environmental gains from injecting room

Reducing offence and alarm caused by public injecting and related litter is a key motivation for establishing supervised injecting facilities, but one rarely subject to scientific scrutiny. This Canadian study established that these benefits really can materialise.

OFFCUT 2005 PDF file 151Kb
Hepatitis C is spreading more rapidly than was thought

From the early 2000s in Britain there was clear evidence from research and routine monitoring that drug policy was failing to contain hepatitis C infection among injectors, and worrying signs of a trend upwards in HIV infection.

STUDY 2005 PDF file 115Kb
Simple interventions cut hepatitis C risk

In Australia a detailed assessment of an injector's risk of becoming infected with hepatitis C was followed by substantial risk reductions not improved on by individualised advice.

STUDY 2005 PDF file 149Kb
Syringe sharing cut by two-thirds after injecting room opens

After showing that the safer injecting facility in Vancouver benefited the community by reducing public injecting and injection-related litter, researchers have now shown that it also safeguarded its users by cutting the number who shared syringes by two-thirds.

STUDY 2005 PDF file 166Kb
Continuity vital after prison treatment

Though the original treatments were diametrically opposed, two long-term follow-up studies have confirmed that post-release continuity is vital to sustain the benefits of treatment in prison.

IN PRACTICE 2004 PDF file 418Kb
Giving the silent majority a voice

Constrained by guidelines and standards, a UK prescribing service could do little to respond to user survey feedback.

STUDY 2004 PDF file 159Kb
Methadone maintenance as low-cost lifesaver

US studies find that even when slow methadone detoxification is bolstered by psychosocial therapy and aftercare, methadone maintenance does better at prolonging the lives of opiate-dependent patients at relatively little extra cost.

REVIEW 2004 PDF file 784Kb
Hepatitis C and needle exchange part 3: the British record

Reveals the paucity of evidence that exchanges in Britain have directly reduced risk behaviour or infection spread, and the hidden flaw in the seminal pilot study. Lack of real impact is probably less the problem than lack of real evidence of impact.

REVIEW 2004 PDF file 1222Kb
Hepatitis C and needle exchange part 4: the active ingredients

Final part of the series pulls together the threads in the form of the limitations which threaten viral control and the practice ingredients which hold promise for the future. A revitalised agenda commensurate with the challenge of hepatitis C.


Select search results page

PREVIOUS | NEXT 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22